Información de la revista
Vol. 53. Núm. 6.
Páginas 610-612 (diciembre 2000)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 53. Núm. 6.
Páginas 610-612 (diciembre 2000)
Acceso a texto completo
Réplica
Visitas
5555
J.A. Soult
Unidad de Cuidados Intensivos-Pediatría. Hospital Virgen del Rocío. Sevilla
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.A. Soult, M. Muñoz, J.D. López, A. Rodriguez, A. Romero, A. Tovaruela.
Continúa el aumento de incidencia de enfermedad meningocócica por serogrupo C. A¿Debemos tomar la decisión de vacunarα.
An Esp Pediatr, 53 (2000), pp. 75-76
[2.]
Advisory Committee on Inmunization Practices (ACIP). Prevention and control of meningococcal disease.
Mmwr, 49 (2000), pp. 1-10
[3.]
F.X. Riedo, B.D. Plikaytis, C.V. Broome.
Epidemiology and prevention of meningococcal disease.
Pediatr Infect Dis J, 14 (1995), pp. 643-657
[4.]
C.M. Whalen, J.C. Hockin, A. Ryan, F. Ashton.
The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992: emergence of a virulent clone of Neisseria meningitidis.
Jama, 273 (1995), pp. 390-394
[5.]
Meningococcal disease-New England, 1993-1998.
Morb Mortal Wkly Rep, 48 (1999), pp. 629-633
[6.]
D.J. Irwin, J.M. Miller, P.C. Milner, T. Patterson, R.G. Richards, D.A. Williams.
Community inmunization programme in response to an outbreak of invasive Neisseria meningitidis serogroup C infection in the Trent region of England 1995-1996.
J Public Health Med, 19(2) (1997), pp. 162-70.7
[7.]
Sistema de Vigilancia Epidemiológica de Andalucía. Enfermedad meningocócica. SVEA 1999; vol 3, n.A 24
[8.]
N. Rosenstein, O. Levine, J. Taylor.
Efficacy of meningococcal vaccine and barriers to vaccination.
Jama, 279 (1998), pp. 435-439
[9.]
C.W. Woods, G. Armtrong, S.O. Sackey, C. Tetteh, S. Bugri, B.A. Perkins.
Emergency vaccination against epidemic meningitis in Ghane: implications for the control of meningococcal disease in West Africa.
[10.]
A. Aplogan, E. Batchassi, Y. Yakoua, A. Croisier, A. Aleki, M. Schlumbetrger.
An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies.
Sante, 7(6) (1997), pp. 384-390
[11.]
G. Campagne, A. Garba, P. Fabre, A. Schuchat, R. Ryall, Boulanger.
Safety and inmunogenicity of three doses of a Neisseria meningitidis A + C conjugate vaccine in infants from Niger.
Pediatr Infect Dis J, 19(2) (2000), pp. 144-150
[12.]
A. Leach, P.A. Twumasi, S. Kumah, W. Banya, S. Jaffar, B. Forrest.
Induction of inmunologic memory in gambian chidren by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.
J Infect Dis, 175 (1997), pp. 200-204
[13.]
N. McDonald, B. Halperin Law, B. Forrest, L. Danzig, D. Granoff.
Induction of inmunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers.
Jama, 280 (1998), pp. 1685-1689
[14.]
P. Richmond, E. Kacmarski, R. Borrow, J. Findlow, S. Clark, R. McCann.
Meningococcal C polysaccharide vaccine induces inmunologic huporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
J Infect Dis, 819 (2000), pp. 761-764
[15.]
J. McLennan, S. Obaro, J. Deeks, D. Williams, L. Pais, G. Carlone.
Inmune response to revaccination with meningococcal A and C polysaccharides in gambian children following repeated inmunisation during early childhood.
Vaccine, 17 (1999), pp. 3086-3093
[16.]
R. Gold, M.L. Lepow, I. Goldschneider, T.F. Draper, E.C. Gotshlich.
Kinetics of antibody production to group C meningococcal polisaccharide vaccines administered during the first six years of life: prospects for rutine inmunization of infant and children.
J Infect Dis, 140 (1979), pp. 690-697
[17.]
M. Drogari, C.A. Fijen, D. Van de Beek, E.F. Hensen, J. Dankert, E.J. Kuijper.
Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement- deficient patients.
Clin Exp Inmunol, 119(2) (2000), pp. 311-316
[18.]
D. Granoff, R. Gupta, R. Belshe, E. Anderson.
Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.
J Infect Dis, 178 (1998), pp. 870-874
[19.]
N.E. Rosenstein, B.A. Perkins, D.S. Stephens.
The changing epidemiology of meningococcal disease in the United states, 1992-1996.
J Infect Dis, 180 (1999), pp. 1894-1901
[20.]
L.H. Harrison.
Preventing meningococcal infection in college students.
Clin Infect Dis, 30(4) (2000), pp. 648-651
[21.]
J.A. Soult, M.C. Macías, C. Martín, F. Ponce, M. Muñoz, M. Menéndez.
Meningitis por Haemophilus influenzae B. Estudio de 99 casos.
An Esp Pediatr, 40(6) (1994), pp. 443-448
Copyright © 2000. Asociación Española de Pediatría
Descargar PDF
Idiomas
Anales de Pediatría
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?